Gary Hammer
Gary Hammer
Verified email at
Cited by
Cited by
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline
SR Bornstein, B Allolio, W Arlt, A Barthel, A Don-Wauchope, GD Hammer, ...
The Journal of Clinical Endocrinology & Metabolism 101 (2), 364-389, 2016
Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression
MW Nachtigal, Y Hirokawa, DL Enyeart-VanHouten, JN Flanagan, ...
Cell 93 (3), 445-454, 1998
Adrenocortical carcinoma
T Else, AC Kim, A Sabolch, VM Raymond, A Kandathil, EM Caoili, S Jolly, ...
Endocrine reviews 35 (2), 282-326, 2014
Pathophysiology of disease: an introduction to clinical medicine
GD Hammer, SJ McPhee, MGH Education
McGraw-Hill Education Medical, 2014
Comprehensive pan-genomic characterization of adrenocortical carcinoma
S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ...
Cancer cell 29 (5), 723-736, 2016
Management of patients with adrenal cancer: recommendations of an international consensus conference
DE Schteingart, GM Doherty, PG Gauger, TJ Giordano, GD Hammer, ...
Endocrine-related cancer 12 (3), 667-680, 2005
Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress
GD Hammer, I Krylova, Y Zhang, BD Darimont, K Simpson, NL Weigel, ...
Molecular cell 3 (4), 521-526, 1999
Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results
GD Hammer, JB Tyrrell, KR Lamborn, CB Applebury, ET Hannegan, ...
The Journal of Clinical Endocrinology & Metabolism 89 (12), 6348-6357, 2004
Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling
TJ Giordano, R Kuick, T Else, PG Gauger, M Vinco, J Bauersfeld, ...
Clinical cancer research 15 (2), 668-676, 2009
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
M Fassnacht, A Berruti, E Baudin, MJ Demeure, J Gilbert, H Haak, ...
The lancet oncology 16 (4), 426-435, 2015
Telomere protection by mammalian Pot1 requires interaction with Tpp1
D Hockemeyer, W Palm, T Else, JP Daniels, KK Takai, JZS Ye, ...
Nature structural & molecular biology 14 (8), 754-761, 2007
Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma
BS Miller, JB Ammori, PG Gauger, JT Broome, GD Hammer, GM Doherty
World journal of surgery 34 (6), 1380-1385, 2010
Recent insights into organogenesis of the adrenal cortex
CE Keegan, GD Hammer
Trends in Endocrinology & Metabolism 13 (5), 200-208, 2002
Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma
FM Barlaskar, AC Spalding, JH Heaton, R Kuick, AC Kim, DG Thomas, ...
The Journal of Clinical Endocrinology & Metabolism 94 (1), 204-212, 2009
Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex
AC Kim, AL Reuter, M Zubair, T Else, K Serecky, NC Bingham, GG Lavery, ...
Oxford University Press for The Company of Biologists Limited 135 (15), 2593 …, 2008
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
P Haluska, F Worden, D Olmos, D Yin, D Schteingart, GN Batzel, ...
Cancer chemotherapy and pharmacology 65 (4), 765-773, 2010
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells
JL Garcia-Perez, M Morell, JO Scheys, DA Kulpa, S Morell, CC Carter, ...
Nature 466 (7307), 769-773, 2010
Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin
JH Heaton, MA Wood, AC Kim, LO Lima, FM Barlaskar, MQ Almeida, ...
The American journal of pathology 181 (3), 1017-1033, 2012
Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma
T Else, AR Williams, A Sabolch, S Jolly, BS Miller, GD Hammer
The Journal of Clinical Endocrinology & Metabolism 99 (2), 455-461, 2014
The system can't perform the operation now. Try again later.
Articles 1–20